PDAPS | Prescription Drug Abuse Policy System

Ibragimov, U., Mansfield, R., Yarbrough, C., Cummings, J., Livingston, M., Haardoerfer, R., Beane, S., Fadanelli, M., Haley, D., & Cooper H. (2022).

Medicaid Expansion and opioid overdose mortality among socioeconomically disadvantaged populations in the US: a difference in differences analysis

Drug and Alcohol Dependence, https://www.sciencedirect.com/science/article/pii/S0376871622001181

Jackson, J., Harle, C., Silverman, R., Simon, K., & Menachemi, N. (2022).

State-level regulations and opioid-related health outcomes

Drug and Alcohol Dependence, https://www.sciencedirect.com/science/article/abs/pii/S037687162200031X

Mathur, N., & Ruhm, C. (2022).

Marijuana Legalization and Opioid Deaths

National Bureau of Economic Research, https://www.nber.org/system/files/working_papers/w29802/w29802.pdf

McGinty, E., Bicket, M., Seewald, N., Stuart, E., Alexander, C., Barry, C., McCourt, A., Rutkow, L. (2022).

Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured U.S. Adults

Annals of Internal Medicine, https://www.acpjournals.org/doi/abs/10.7326/M21-4363

Shakya, S., & Harris S. (2022).

Medicaid Expansion and Opioid Supply Policies to Address the Opioid Crisis

Drug and Alcohol Dependence, https://www.sciencedirect.com/science/article/pii/S2772724622000208

Smiley-McDonald, H., Attaway, P., Richardson, N., Davidson, P., & Kral, A. (2022).

Perspectives from law enforcement officers who respond to overdose calls for service and administer naloxone

Health & Justice, https://link.springer.com/article/10.1186/s40352-022-00172-y

Stith, S. (2022).

Effects of work requirements for food assistance eligibility on disability claiming

IZA Journal of Labor Economics, https://doi.org/10.2478/izajole-2022-0002

Vuolo, M., Frizell, L., & Kelly, Brain C. (2022).

Surveillance, Self-Governance, and Mortality: The Impact of Prescription Drug Monitoring Programs on U.S. Overdose Mortality, 2000–2016

Journal of Health and Social Behavior, https://journals.sagepub.com/doi/abs/10.1177/00221465211067209

Abouk, R. et al. (2021).

Does Marijuana Legalization Affect Work Capacity? Evidence from Workers’ Compensation Benefits

NBER Working Paper, https://www.nber.org/papers/w28471

Abouk, R., & Powell, D. (2021).

Can electronic prescribing mandates reduce opioid-related overdoses?

Economics & Human Biology, https://www.sciencedirect.com/science/article/pii/S1570677X21000241

Anwar, T., & Jayawardhana, J. (2021).

The association between pill mill legislation and neonatal abstinence syndrome

Journal of Pharmaceutical Health Services Research, https://academic.oup.com/jphsr/advance-article-abstract/doi/10.1093/jphsr/rmab069/6490151

Brandt, L., Yanagida, T., Campbell, A., Jermaine, D., Jones, M., Martinez, & Comer, S. (2021).

Multi-informant Implementation and Intervention Outcomes of Opioid Overdose Education and Naloxone Distribution in New York City

Global Implementation Research and Applications, https://link.springer.com/article/10.1007/s43477-021-00021-4

Bohler, R., Hodgkin, D., Kreiner, P., & Green, T. (2021).

Predictors of US States' Adoption of Naloxone Access Laws, 2001-2017

Drug and Alcohol Dependence, https://www.sciencedirect.com/science/article/abs/pii/S0376871621002672

Camercon, G., Chandra, R. Ivey, M., Khatri, S., Nemire, R., Quinn, J., & Subramaniam, V. (2021).

ASHP Statement on the Pharmacist's Role in Public Health

American Journal of Health-System Pharmacy, https://academic.oup.com/ajhp/advance-article-abstract/doi/10.1093/ajhp/zxab338/6388086

Decker, S., Dworsky, M., Gibson, T., Henke, R., & McDermott, K. (2021).

The Impact of the Affordable Care Act Insurance Expansions on Opioid-Related Emergency Department Visits

Health Services Research, https://onlinelibrary.wiley.com/doi/abs/10.1111/1475-6773.13787

Elliot, J. et al. (2021).

Naloxone Availability in Community Pharmacies

Substance Abuse, Treatment, Prevention, and Policy (preprint), https://www.researchsquare.com/article/rs-340874/v1

Ellyson, A., Grooms, J., & Ortega, A. (2021).

Flipping the Script: the effects of opioid prescription monitoring on specialty-specific provider beahvior

https://static1.squarespace.com/static/57c9d7602994ca1ac7d06b71/t/615ee3c7198b5c2ace6156de/1633608648756/Physcian_PDMP_Ellyson_et_al_Aug_2021_Draft.pdf

Farley, N. (2021).

Medical Street Wisdom: A Community-based Study on the Precarity and Utility of Unapproved Opioid Overdose Reversal Techniques among Syringe Exchange Clientele

University of California, Santa Barbara, https://escholarship.org/content/qt5j08q4jf/qt5j08q4jf.pdf

Gottschalk, M. (2021).

No Star State: What's Right and Wrong About Criminal Justice Reform in Texas

Seattle Journal for Social Justice, https://digitalcommons.law.seattleu.edu/cgi/viewcontent.cgi?article=2067&context=sjsj

Guggino, K. (2021).

Are Prescription Drug Monitoring Programs Effective? An Analysis of the Impact of Prescription Drug Monitoring Programs (PDMPs) Operational Variation on Prescription Opioid Misuse and Abuse

University of Maryland, Baltimore County, ProQuest Dissertations Publishing, https://www.proquest.com/openview/f7b53fe374ee3bc604adddc2de1c9371/1?pq-origsite=gscholar&cbl=18750&diss=y

Guth D., & Zhang, S. (2021).

Geographic Spillover Effects of Prescription Drug Monitoring Programs (PDMPs)

N/A, https://arxiv.org/pdf/2107.04925.pdf

Haas, E. (2021).

Health and Social Services F-4 The Opioid Crisis

Kansas Legislator Briefing Book 2019, http://www.kslegresearch.org/KLRD-web/Publications/BriefingBook/2019Briefs/F-4-TheOpioidCrisis.pdf

Hamilton, L., Davis, C., Kravitz-Wirtz, N., Ponicki, W., & Cerdá, C. (2021).

Good Samaritan laws and overdose mortality in the United States in the fentanyl era

International Journal of Drug Policy, https://www.sciencedirect.com/science/article/abs/pii/S0955395921002000

Hasin, D., Borodovsky, J., Shmulewitz, D., Walsh, C., Livne, O., Struble, C., Aharonovich, E., Fink, D., & Budney, A. (2021).

Use of highly-potent cannabis concentrate products: more common in U.S. states with recreational or medical cannabis laws

Drug and Alcohol Dependence, https://www.sciencedirect.com/science/article/abs/pii/S0376871621006542

Hsu, G., & Kovács, B. (2021).

Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study

The BMJ, https://www.bmj.com/content/372/bmj.m4957

Jayawardhana, J. (2021).

Impact of Medicaid expansion on mental health and substance use related emergency department visits

Substance Abuse, https://www.tandfonline.com/doi/abs/10.1080/08897077.2021.1941521

Jayawardhana, J., & Fernandez, J. (2021).

The associations of medical marijuana policies with opioid‐related health care utilization

Health Services Research, https://onlinelibrary.wiley.com/doi/abs/10.1111/1475-6773.13632

Kelly, B., Vuolo, M. (2021).

Do naloxone access laws affect perceived risk of heroin use? Evidence from national US data

Addiction, https://onlinelibrary.wiley.com/doi/abs/10.1111/add.15682

Kelly, B., Vuolo, M., & Frizzell., L (2021).

Pediatric drug overdose mortality: contextual and policy effects for children under 12 years

Pediatric Research, https://www.nature.com/articles/s41390-021-01567-7

Kohan, L. (2021).

Naloxone for the Pain Physician: What Do I Need to Know?

ASRA, https://www.asra.com/the-asra-family/special-interest-groups/cannabis-in-acute-and-chronic-pain/cannabis-sig-article/asra-news/2021/02/01/naloxone-for-the-pain-physician-what-do-i-need-to-know

Le, A. (2021).

Essays on the role of policies public health issues

University of Kentucky, UKnowledge, https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1055&context=economics_etds

Ma, S. (2021).

The Effect of Monitoring Frequency on Prescription Opioids Overdose Death Rate

Towards Data Science, https://towardsdatascience.com/the-effect-of-monitoring-frequency-on-prescription-opioids-overdose-death-rate-ccb4c9c741dd

McGinty, E. et al. (2021).

Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes

Implementation Science, https://link.springer.com/article/10.1186/s13012-020-01071-2

Meinhofer, A., Witman, Alison., Hinde, J., & Simon, K. (2021).

Marijuana liberalization policies and perinatal health

Journal of Health Economics, https://www.sciencedirect.com/science/article/abs/pii/S0167629621001223

Metha, H., Kuo, Y., Raji, M., Westra, J., Boyd, C., Alexander, C., & Goodwin, J. (2021).

State Variation in Chronic Opioid Use in Long-Term Care Nursing Home Residents

Journal of the American Medical Directors Association, https://www.sciencedirect.com/science/article/abs/pii/S1525861021003947

Meyerson, B., Moehling, T., Agley, J., Coles, H., & Phillips, J. (2021).

Insufficient Access: Naloxone Availability to Laypeople in Arizona and Indiana, 2018

Journal of Health Care for the Poor and Underserved, https://muse.jhu.edu/article/794650/summary

Miller, S., Johnson, N., & Wherry, L. (2021).

Medicaid and Mortality: New Evidence from Linked Survey and Administrative Data

NBER Working Paper, https://www.nber.org/papers/w26081

Mohammad, I., Berri, D., Lehr, V. (2021).

Pharmacists and Opioid Use Disorder Care During COVID-19: Call for Action

Journal of the American College of Clinical Pharmacy, https://accpjournals.onlinelibrary.wiley.com/doi/abs/10.1002/jac5.1556

Mumma, B., Macias-Konstantopoulos, W., & Stoklosa, H. (2021).

Human Trafficking 21

Social Emergency Medicine: Principles and Practice, https://books.google.com/books?id=t5RBEAAAQBAJ&lpg=PA350&dq=%22Prescription%20Drug%20Abuse%20Policy%20System%22&lr=lang_en&pg=PA354#v=onepage&q=%22Prescription%20Drug%20Abuse%20Policy%20System%22&f=false

Parth S. et al. (2021).

Availability of Naloxone in 2 Underserved Urban Communities in Georgia

Journal of Public Health Management and Practice, https://journals.lww.com/jphmp/Fulltext/2021/05001/Availability_of_Naloxone_in_2_Underserved_Urban.14.aspx

Pessar, S., Boustead, A., & Ge, Y. (2021).

Assessment of State and Federal Health Policies for Opioid Use Disorder Treatment During the COVID-19 Pandemic and Beyond

JAMA Health Forum, https://jamanetwork.com/journals/jama-health-forum/fullarticle/2786441

Pham, H. (2021).

The role of insurance coverage in outpatient substance use disorder treatment referral, utilization, and outcomes

Virginia Commonwealth University, https://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=7860&context=etd

Pham, T. (2021).

Employment and Drug-Related Mortality

Boise State University, https://scholarworks.boisestate.edu/cgi/viewcontent.cgi?article=2929&context=td

Rolando, S., Beccaria, F., Ronconi, S. (2021).

Benefits and barriers associated with take-home-naloxone in the view of Italian service providers

Drugs and Alcohol Today, https://www.emerald.com/insight/content/doi/10.1108/DAT-12-2020-0077/full/html

Rouhani, S., Schneider, K., Rao, A., Urquhart, G., Morris, M., LaSalle, L., & Sherman, S. (2021).

Perceived vulnerability to overdose-related arrests among people who use drugs in Maryland

International Journal of Drug Policy, https://www.sciencedirect.com/science/article/abs/pii/S0955395921003315

Sabia, J., Dave, D., Alotaibi, F., & Rees, D. (2021).

Is Recreational Marijuana a Gateway to Harder Drug Use and Crime?

National Bureau of Economic Research, https://www.nber.org/system/files/working_papers/w29038/w29038.pdf

Samuels, E., Xuan, Z., & Bernstein, E. (2021).

Substance Use: A Social Emergency Medicine Perspective

Social Emergency Medicine: Principles and Practice, https://link.springer.com/chapter/10.1007/978-3-030-65672-0_10

Samuels, E., Xuan, Z., & Bernstein, E. (2021).

Sim, Yongbo

https://ybshim87.github.io/Materials/JMP_Ysim_OxyCrime.pdf

Schauer, G. (2021).

Cannabis Policy in the United States: Implications for Public Health

JNCI Monographs https://academic.oup.com/jncimono/article/2021/58/39/6446219?login=true

Shakya, S. (2021).

Three Essays on Health Economics and Policy Evaluation

Graduate Theses, Dissertationsm and Problem Reports, West Virgina University, https://researchrepository.wvu.edu/cgi/viewcontent.cgi?article=8745&context=etd

Shealy, K., & Strand, M. (2021).

Safe opioid use in the community setting: reverse the curse?

Milne Library, https://milnepublishing.geneseo.edu/publichealthforpharmacy/chapter/safe-opioid-use-in-the-community-setting-reverse-the-curse/

Shealy, K., & Strand, M. (2021).

Safe opioid use in the community setting: reverse the curse?

Public Health in Pharmacy Practice, https://scholar.google.com/scholar_url?url=https://knightscholar.geneseo.edu/cgi/viewcontent.cgi%3Ffilename%3D0%26article%3D1026%26context%3Doer-ost%26type%3Dadditional%23page%3D54&hl=en&sa=X&d=14695203422191946462&ei=cjpoYYrOEaPZsQLAgJLgBA&scisig=AAGBfm1H6_HUj9p2pMQLaa0-FQFQDdv-gA&oi=scholaralrt&html=&folt=kw

Stein, B., Sheng, F., Taylor, E., Dick, A., Sorbero, M., & Pacula, R. (2021).

The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic

Drug and Alcohol Dependence, https://www.sciencedirect.com/science/article/pii/S0376871621007274

Taylor, J., Johnson, S., Cruz, R., Gray, J., Schiff, D., & Bagley, S. (2021).

Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings

Journal of General Internal Medicine, https://link.springer.com/article/10.1007/s11606-021-06904-4

Tormohlen, K., Bicket, M., White, S., Barry, C., Stuart, E., Rutkow, L., McGinty, E. (2021).

The State of the Evidence on the Association Between State Cannabis Laws and Opioid-Related Outcomes: a Review

Current Addiction Reports, https://link.springer.com/article/10.1007/s40429-021-00397-1

Vuolo, M. Kelly, B. (2021).

Effects of County-Level Opioid Dispensing Rates on Individual-Level Patterns of Prescription Opioid and Heroin Consumption: Evidence From National U.S. Data

The American Journal of Psychiatry, https://ajp.psychiatryonline.org/doi/abs/10.1176/appi.ajp.2021.21060602

Wang, L. (2021).

The complementarity of drug monitoring programs and health IT for reducing opioid-related mortality and morbidity

Wiley, https://onlinelibrary.wiley.com/doi/pdf/10.1002/hec.4360

Xavier, J., Greer, A., Crabtree, A., Ferencz, S., & Baxton, J. (2021).

Police officers' knowledge, understanding and implementation of the Good Samaritan Drug Overdose Act in BC, Canada

International Journal of Drug Policy, https://www.sciencedirect.com/science/article/pii/S0955395921003157

Xu, J., & Mukherjee, S (2021).

State laws that authorize pharmacists to prescribe naloxone are associated with increased naloxone dispensing in retail pharmacies

Drug and Alcohol Dependence, https://www.sciencedirect.com/science/article/abs/pii/S037687162100507X

Adams, N. Gundlach, E. & Cheng C. (2020).

An Analysis of State-Level Policies and Opioid Overdose Deaths.

Western Journal of Nursing Research, https://journals.sagepub.com/doi/full/10.1177/0193945919897538

Amaram-Davila, J., Mallipeddi, T., & Reddy, A. (2020).

Opioid Prescribing with Take-Home Naloxone: Rationale and Recommendations.

Current Anesthesiology Reports, https://link.springer.com/article/10.1007/s40140-020-00419-0

Burris, S. (2020).

Research on the Effects of Legal Health Interventions to Prevent Overdose: Too Often Too Little and Too Late

American Journal of Public Health, https://doi.org/10.2105/AJPH.2020.305678

Cerdá, M, et al. (2020).

A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic

Annual Review of Public Health, https://www.annualreviews.org/doi/abs/10.1146/annurev-publhealth-090419-102727

Clemans-Cope, L., Epstein, M., & Winiski, E. (2020).

Naloxone Products and Their Pricing in Medicaid, 2010-18: Trends for Opioid Overdose Reversal Drugs

Urban Institute, https://www.urban.org/sites/default/files/publication/102769/naloxone-products-and-their-pricing-in-medicaid-2010-18.pdf

Comartin, E., Nelson, V., Hambrick, N., Kubiak, S., Sightes, E., & Ray, B. (2020).

Comparing For-Profit and Nonprofit Mental Health Services in County Jails

The Jounral of Behavioral Health Services and Research, https://link.springer.com/article/10.1007/s11414-020-09733-1

Darnell, A. (2020).

Review of Scientific Evidence on Effects of Medical and Non-medical Marijuana Legalization on Public Health in the United States

Report coordinated by the French Monitoring Centre for Drugs and Drug Addiction, https://en.ofdt.fr/BDD/publications/docs/ASTRACAN-Darnell-EN.pdf

Davidson, P., Chakrabarti, P., & Marquesen, M. (2020).

Impacts of mandated data collection on syringe distribution programs in the United States

International Journal of Drug Policy, https://www.sciencedirect.com/science/article/abs/pii/S0955395920300669

Dunsby, C. (2020).

Naloxone Access and Opioid Use: A Theoretical Analysis

Honors Theses, Colby College, https://digitalcommons.colby.edu/cgi/viewcontent.cgi?article=2014&context=honorstheses

Earnshaw, V. (2020).

Stigma and substance use disorders: A clinical, research, and advocacy agenda

American Psychologist, https://psycnet.apa.org/record/2020-99903-024

Ellyson, A., Grooms, J., & Ortega, A. (2020).

Flipping the Script: Evaluating the Policy Effects and Restrictiveness of PDMPs on Opioid Prescribing Behavior.

University of Washington, Working Paper, https://static1.squarespace.com/static/57c9d7602994ca1ac7d06b71/t/5efb7677b000c34cccb64ffb/1593538172758/Flipping_the_Script_Ellyson_et_al.pdf

Everson, J. et al. (2020).

Association of Electronic Prescribing of Controlled Substances With Opioid Prescribing Rates

JAMA Network Open, https://jamanetwork.com/journals/jamanetworkopen/article-abstract/2774352

Fine, D., Herzberg, D., & Wakerrman, S. (2020).

Societal Biases, Institutional Discrimination, and Trends in Opioid Use in the USA.

Journal of General Internal Medicine, https://link.springer.com/article/10.1007/s11606-020-05974-0

Frizzell, L., Vuolo, M., & Kelly, B. (2020).

State pain management clinic policies and county opioid prescribing: A fixed effects analysis.

Drug & Alcohol Dependence, https://www-sciencedirect-com.libproxy.temple.edu/science/article/pii/S037687162030404X

Ghimire, K. & Maclean, J. (2020).

Medical marijuana and workers' compensation claiming

Health Economics, https://onlinelibrary.wiley.com/doi/abs/10.1002/hec.3992

Gupta, S., Nguyen, T., Freeman, P., & Simon, K. (2020).

Competitive Effects of Federal and State Opioid Restrictions: Evidence from the Controlled Substance Laws

National Bureau of Economic Research (NBER) Working Paper No. 27520, https://www.nber.org/papers/w27520

Horowitz JR. et al. (2020).

The importance of data source in prescription drug monitoring program research

Health Services Research, https://onlinelibrary.wiley.com/doi/abs/10.1111/1475-6773.13548

Jacksona, J. R., Harle, C., Silverman, R., Simon, K., & Menachemib, N. (2020).

Characterizing variability in state-level regulations governing opioid treatment programs

Journal of Substance Abuse Treatment, https://www.sciencedirect.com/science/article/abs/pii/S0740547219307081

Jones, J., Campbell, A., Brandt, L., Castillo, F., Abbott, R., Comer, S. (2020).

Intervention in an opioid overdose event increases interest in treatment among individuals with opioid use disorder

Substance Abuse, https://www-tandfonline-com.libproxy.temple.edu/doi/full/10.1080/08897077.2020.1809607

Kim, C., Lefkowitsb, C., Holschneiderc, C., Bixeld, K., & Pothurie, B. (2020).

Managing opioid use in the acute surgical setting: A society of gynecologic oncology clinical practice statement

Gynecologic Oncology, https://www.gynecologiconcology-online.net/article/S0090-8258(20)30068-8/fulltext

Mackert, M., Pounders, K., Brown, L., Kirtz, S., Wagner, J., Ring, D., Hill, L., Wilcox, G., Murthy, D., Tierney, W., Innerarity, S., McGlone, M., Steiker, L., DeSalvo, K., Bernhardt J., & Pretorius, K. (2020).

Development of a health communication campaign to promote the Texas prescription monitoring program

Health Marketing Quarterly, https://www.tandfonline.com/doi/abs/10.1080/07359683.2020.1802967

Magne, T. (2020).

Essays on the Affordable Care Act Mandates and Their Effects on Labor Supply and Health Outcomes

University of Delaware, ProQuest Dissertations Publishing, https://search-proquest-com.libproxy.temple.edu/docview/2456362783?pq-origsite=gscholar&fromopenview=true

Mallinson, D., & Hannah, A. (2020).

Policy and Political Learning: The Development of Medical Marijuana Policies in the States

The Journal of Federalism, https://academic.oup.com/publius/article-abstract/doi/10.1093/publius/pjaa006/5819235

McMichael, B. (2020).

Occupational Licensing and the Opioid Crisis

UC Davis Law Review, https://lawreview.law.ucdavis.edu/issues/54/2/articles/files/54-2_McMichael_color.pdf

Moallef, S., & Hayashi, K. (2020).

The effectiveness of drug-related Good Samaritan laws: A review of the literature

International Journal of Drug Policy, https://www.sciencedirect.com/science/article/abs/pii/S0955395920301146

Nguyen, J. et al. (2020).

Availability of Naloxone at Rural Georgia Pharmacies, 2019

JAMA Network Open, https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2760889

Pauly, N., Goodin, A. (2020).

Chapter 51: Health Policy and Pharmacy

Remington: The Science and Practice of Pharmacy (23rd ed.), https://www.sciencedirect.com/science/article/pii/B9780128200070000490

Schneider K. et al. (2020).

Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone

International Journal of Drug Policy, https://www.sciencedirect.com/science/article/pii/S095539591930355X

Schuler, M., Griffin, B., Cerdá, M., McGinty, E., & Stuart, E. (2020).

Methodological challenges and proposed solutions for evaluating opioid policy effectiveness

Health Services and Outcomes Research Methodology, https://link.springer.com/article/10.1007/s10742-020-00228-2

Shakya, S. (2020).

County Level Assessment of Prescription Drug Monitoring Program and Opioid Prescription Rate

John Chambers College of Business and Economics & Regional Research Institute (RRI), West Virginia University https://shishirshakya.github.io/files/Papers/County_Level_Assessment_of_Prescription_Drug_Monitoring_Program_and_Opioid_Prescription_Rate.pdf

Sohn, M. et al. (2020).

Association between state Medicaid expansion status and naloxone prescription dispensing

Health Services Research, https://onlinelibrary.wiley.com/doi/full/10.1111/1475-6773.13266

Tan de Bibiana, J., Miller, C., Pope, L., Stellin, S., Parsons, J., & Cloud, D. (2020).

Changing Course in the Overdose Crisis: Moving from Punishment to Harm Reduction and Health

Vera, Institute of Justice, https://www.vera.org/downloads/publications/changing-course-in-the-overdose-crisis.pdf

Tibbitts, J., & Cowan, B. (2020).

The Opioid Safety Initiative and Veteran Suicides

Washington State University, School of Economic Sciences, http://ses.wsu.edu/wp-content/uploads/2020/10/OSI-JMP.pdf

Toce, M., Michelson, K., & Hudgins, J. et al. (2020).

Association of State-Level Opioid-Reduction Policies With Pediatric Opioid Poisoning

JAMA Pediatrics, https://jamanetwork.com/journals/jamapediatrics/article-abstract/2768207

Wang, Z. (2020).

Applications of Data Science Methods in Discovering Opioid Prescribing Patterns and the Mechanisms Underlying Substance Use Initiation and Addiction

Indiana University, ProQuest Dissertations Publishing, https://search.proquest.com/openview/24f780ba69eacefa6fe690798af6f36e/1?pq-origsite=gscholar&cbl=51922&diss=y

Waskell EN, et al. (2020).

The impact of medical school education on the opioid overdose crisis with concurrent training in naloxone administration and MAT

Journal of Addictive Diseases, https://www.tandfonline.com/doi/abs/10.1080/10550887.2020.1762030

Williams, N. (2020).

Media Portrayals of Drug Use and Users

Indiana University of Pennsylvania (Dissertation), https://search.proquest.com/openview/d80088c9c1735484c6d0dbb773b080e1/1?pq-origsite=gscholar&cbl=18750&diss=y

Winkler, A., Tobin, K., Gicquelais, R., Owczarzak, J., & Latkin, C. (2020).

“When You're Getting High… You Just Don't Want to Be Around Anybody.” A Qualitative Exploration of Reasons for Injecting Alone: Perspectives from Young People Who Inject Drugs

Substance Use and Misuse, https://www.tandfonline.com/doi/abs/10.1080/10826084.2020.1790008

Allen, S.T., Hamilton White, R., O’Rourke, A., Grieb, S.M., Kilkenny, M.E., Sherman, S.G. (2019).

Take-home naloxone possession among people who inject drugs in rural West Virginia.

Drug and Alcohol Dependence, Vol. 204, November 1, 2019. https://doi.org/10.1016/j.drugalcdep.2019.107581

Bach, P., Hartung, D. (2019).

Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders. 14:30.

Addiction Science & Clinical Practice. 14:30. https://doi.org/10.1186/s13722-019-0158-0

Cariveau, D., Fay, A.E., Baker, D., Fagan, E.B., Gilmore Wilson, C. (2019).

Evaluation of a pharmacist-led naloxone coprescribing program in primary care.

Journal of the American Pharmacists Association, Volume 0, Issue 0. https://doi.org/10.1016/j.japh.2019.07.012

Chan, N.W., Burkhardt, J., Flyr, M. (2019).

The Effects of Recreational Marijuana Legislation and Dispensing on Opioid Mortality.

Econ Inq. doi:10.1111/ecin.12819.

Chisholm-Burns, M.A., Spivey, C.A., Sherwin, E., Wheeler, J., Hohmeier, K. (2019).

The opioid crisis: Origins, trends, policies, and the roles of pharmacists.

American Journal of Health-System Pharmacy, 76(7), 424-435, doi: https://doi.org/10.1093/ajhp/zxy089

Desai, R.J., Jin, Y., Franklin, P.D., Lee, Y.C., Bateman, B.T., Lii, J., Solomon, D.H., Katz, J.N., Kim, S.C. (2019).

Association of Geography and Access to Health Care Providers with Long-Term Prescription Opioid Use in Medicare Patients with Severe Osteoarthritis: A Cohort Study.

Arthritis & Rheumatology, 71:5, 712-721, May 2019. https://doi.org/10.1002/art.40834

Diang L, Shi Y. (2019).

The association between pain clinic laws and prescription opioid exposures: New evidence from multi-state comparisons.

Drug and Alcohol Dependence, https://www.sciencedirect.com/science/article/pii/S0376871619305319

Donohue, J.M., Kennedy, J.N., Seymour, C.W., Girard, T.D., Lo-Ciganic, W.H., Kim, C.H., Marroquin, O.C., Moyo, P., Chang, C.C.H., Angus, D.C. (2019).

Patterns of opioid administration among opioid-naive inpatients and associations with postdischarge opioid use.

Ann. Intern. Med. Published online June 18, 2019. doi:10.7326/M18-2864

Fletcher, J., Molloy, M., Hart, A., Voskanyan, A., Sarin, R., & Ciottone, G. (2019).

Evolution of United States Legislation to Facilitate Bystander Response to Opioid Overdose.

Prehospital and Disaster Medicine, 34(S1), S130-S130. doi:10.1017/S1049023X19002826

Frank, R.G., Fry, C.E. (2019).

The Impact of Expanded Medicaid Eligibility on Access to Naloxone.

Addiction. https://doi.org/10.1111/add.14634

Fudin, J., Persico, A. L., Bettinger, J. J., & Wegrzyn, E. L. (2019).

The state of naloxone: Access amid a public health crisis.

Medicine Access @ Point of Care. https://doi.org/10.1177/2399202619847639

Haas, E. (2019).

Health and Social Services F-4 The Opioid Crisis

Kansas Legislator Briefing Book 2019, http://www.kslegresearch.org/KLRD-web/Publications/BriefingBook/2019Briefs/F-4-TheOpioidCrisis.pdf

Haffajee, R., French, C.A. (2019).

Provider Perceptions of System-Level Opioid Prescribing in Addiction Treatment Policies.

Current Opinion in Psychology 2019. doi: https://doi.org/10.016/j.copsyc.2019.01.018

Hohmann, L. (2019).

An untapped potential in addressing the opioid epidemic.

Journal of the American Pharmacists Association 59, 625-627. https://www.japha.org/article/S1544-3191(19)30358-9/pdf

Kravitz-Wirtz N. et al. (2019).

Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.

JAMA Network Open, https://jamanetwork.com/journals/jamanetworkopen/article-abstract/2758476

Lowenstein, M., Hossain, E., Yang, W., Grande, D., Perrone, J., Neuman, M.D., Ashburn, M., Delgado, M.K. (2019).

Impact of a State Opioid Prescribing Limit and Electronic Medical Record Alert on Opioid Prescriptions: a Difference-in-Differences Analysis.

J. Gen. Intern. Med. https://doi.org/10.1007/s11606-019-05302-1

Martins, S.S., Ponicki, W., Smith, N., Rivera-Aguirre, A., Davis, C.D., Fink, D.S., Castillo-Carniglia, A., Henry, S.G., Marshall, B.D.L., Gruenewald, P., Cerda, M. (2019).

Prescription drug monitoring programs operational characteristics and fatal heroin poisoning.

Int’l J. of Drug Policy, 74: 174-180. https://doi.org/10.1016/j.drugpo.2019.10.001

Moyo, P., Simoni-Wastila, L., Griffin, B.A., Harrington, D., Alexander, G.C., Palumbo, F., & Onukwugha, E. (2019).

Prescription drug monitoring programs: Assessing the association between “best practices” and opioid use in Medicare.

Health Serv. Res. 2019; 00. 1-10. https://doi.org/10.1111/1475-6773.13197

Ruhm, C. (2019).

Drivers of the fatal drug epidemic.

Journal of Health Economics, 64 (2019) 25-42. doi: https://doi.org/10.1016/j.healeco.2019.01.001

Smart R., Kase C., Taylor E., Stein B. (2019).

Strengths and Weaknesses of Existing Data Sources to Support Research to Address the Opioids Crisis.

Preventive Medicine Reports, https://doi.org/10.1016/j.pmedr.2019.101015

Smith, J.O., Malinowski, S.S., Ballou, J.M. (2019).

Public perceptions of naloxone use in the outpatient setting.

Mental Health Clinician: July 2019, Vol. 9, No. 4, pp. 275-279. https://doi.org/10.9740/mhc.2019.07.275

Strang, J., McDonald, R., Campbell, G., Degenhardt, L., Nielsen, S., Ritter, A., & Dale, A. (2019).

Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine.

Drugs, 1-24. https://doi.org/10.1007/s40265-019-01154

Strickler, G.K., Zhang, K., Halpin, J.F., Bohnert, A.S.B., Baldwin, G.T., Kreiner, P.W. (2019).

Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.

Drug and Alcohol Dependence, 199, 1-9. https://doi.org/10.1016/j.drugalcdep.2019.02.010

Whitmore, C.C., White, M.N., Buntin, M.B., Fry, C.E., Calamari, K., Patrick, S.W. (2019).

State laws and policies to reduce opioid-related harm: A qualitative assessment of PDMPs and naloxone programs in ten U.S. States.

Preventative Medicine Reports, 13, 249-255, March 2019. https://doi.org/10.1016/j.pmedr.2018.12.014

Yarbrough, C.R., Abraham, A.J., Bagwell Adams, G. (2019).

Relationship of county opioid epidemic severity to changes in access to substance use disorder treatment, 2009-2017.

Psychiatric Services, Psychiatry Online. https://doi.org/10.1176/appi.ps.201900150

Alexandra, S., Fahad, K., Alina, B., Germaine, C., Christopher, G., & V., D. L. (2018).

New York Physicians' Perspectives and Knowledge of the State Medical Marijuana Program.

Cannabis and Cannabinoid Research, 3(1), 74-84. doi: 10.1089/can.2017.0046

Bennett, A. S., Bell, A., Doe-Simkins, M., Elliott, L., Pouget, E., & Davis, C. (2018).

From Peers to Lay Bystanders: Findings from a Decade of Naloxone Distribution in Pittsburgh, PA.

Journal of Psychoactive Drugs, 1-7. doi: 10.1080/02791072.2018.1430409

Buchmueller, T. C., & Carey, C. (2018).

The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare.

American Economic Journal: Economic Policy, 10(1), 77-112. doi: doi: 10.1257/pol.20160094

Freeman, P. R., Hankosky, E. R., Lofwall, M. R., & Talbert, J. C. (2018).

The changing landscape of naloxone availability in the United States, 2011 – 2017.

Drug and Alcohol Dependence, 191, 361-364. doi: https://doi.org/10.1016/j.drugalcdep.2018.07.017

Gertner, A. K., Domino, M. E., & Davis, C. S. (2018).

Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid.

Drug Alcohol Depend, 190, 37-41. doi: 10.1016/j.drugalcdep.2018.05.014

Goldberg, S. A., Dworkis, D. A., Liao, V. T., Eyre, A. J., Albert, J., Fawcett, M. M., . . . Weiner, S. G. (2018).

Feasibility of Bystander Administration of Public-Access Naloxone for Opioid Overdose.

Prehospital Emergency Care, 1-7. doi: 10.1080/10903127.2018.1461284

Huang, L. C. (2018).

Opioid Overdoses: A Webliography.

Journal of Consumer Health on the Internet, 22(1), 42-52. doi: 10.1080/15398285.2018.1415597

McClellan, C., Lambdin, B. H., Ali, M. M., Mutter, R., Davis, C. S., Wheeler, E., . . . Kral, A. H. (2018).

Opioid-overdose laws association with opioid use and overdose mortality.

Addictive Behaviors, 86, 90-95. doi: https://doi.org/10.1016/j.addbeh.2018.03.014

Pauly, N. J., Slavova, S., Delcher, C., Freeman, P. R., & Talbert, J. (2018).

Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings.

Drug and Alcohol Dependence, 184, 26-32. doi: https://doi.org/10.1016/j.drugalcdep.2017.12.002

Xu, J., Davis, C. S., Cruz, M., & Lurie, P. (2018).

State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies.

Drug & Alcohol Dependence, 189, 37-41. doi: 10.1016/j.drugalcdep.2018.04.020

Lambdin, B. H., Zibbell, J., Wheeler, E., & Kral, A. H. (2018).

Identifying gaps in the implementation of naloxone programs for laypersons in the United States.

International Journal of Drug Policy, 52, 52-55. doi: https://doi.org/10.1016/j.drugpo.2017.11.017

W. Ling, V. Nadipelli, N. Ronquest, V. Albright, A. Aldridge, S. Learned, V. Mehra, C. Heidbreder,

Remission from chronic opioid use—Studying environmental and socio-economic factors on recovery (RECOVER): Study design and participant characteristics. Concli (2018),

https://doi.org/10.1016/j.cct.2018.11.015

Burris, S. (2017).

Theory and methods in comparative drug and alcohol policy research: Response to a review of the literature.

International Journal of Drug Policy, 41, 126-131. doi: http://dx.doi.org/10.1016/j.drugpo.2016.11.011

Compton, W. M., Volkow, N. D., & Lopez, M. F. (2017).

Medical marijuana laws and cannabis use: Intersections of health and policy.

JAMA Psychiatry, 74(6), 559-560. doi: 10.1001/jamapsychiatry.2017.0723

Cushman, P. A., Liebschutz, J. M., Hodgkin, J. G., Shanahan, C. W., White, J. L., Hardesty, I., & Alford, D. P. (2017).

What do providers want to know about opioid prescribing? A qualitative analysis of their questions.

Substance Abuse, 38(2), 222-229. doi: 10.1080/08897077.2017.1296525

Davis, C., & Carr, D. (2017).

State legal innovations to encourage naloxone dispensing.

Journal of the American Pharmacists Association, 57(2, Supplement), S180-S184. doi: https://doi.org/10.1016/j.japh.2016.11.007

Klieger, S. B., Gutman, A., Allen, L., Pacula, R. L., Ibrahim, J. K., & Burris, S. (2017).

Mapping medical marijuana: State laws regulating patients, product safety, supply chains and dispensaries, 2017.

Addiction, n/a-n/a. doi: 10.1111/add.13910

Lapham, G. T., Lee, A. K., Caldeiro, R. M., McCarty, D., Browne, K. C., Walker, D. D., . . . Bradley, K. A. (2017).

Frequency of Cannabis Use Among Primary Care Patients in Washington State.

The Journal of the American Board of Family Medicine, 30(6), 795-805. doi: 10.3122/jabfm.2017.06.170062

Pardo, B. (2017).

Do more robust prescription drug monitoring programs reduce prescription opioid overdose?

Addiction, 112(10), 1773-1783. doi: 10.1111/add.13741

Volkow, N. D., Compton, W. M., & Wargo, E. M. (2017).

The risks of marijuana use during pregnancy.

JAMA, 317(2), 129-130. doi: 10.1001/jama.2016.18612

Burris, S., Hitchcock, L., Ibrahim, J. K., Penn, M., & Ramanathan, T. (2016).

Policy Surveillance: a Vital Public Health Practice Comes of Age.

Journal of Health Politics, Policy & Law, 41(6), 1151-1167. doi: 10.1215/03616878-3665931

Davis, C. S., Burris, S., Beletsky, L., & Binswanger, I. (2016).

Co-prescribing naloxone does not increase liability risk.

Substance Abuse, 37(4), 498-500. doi: 10.1080/08897077.2016.1238431

Kitch, B. B., & Portela, R. C. (2016).

Effective Use of Naloxone by Law Enforcement in Response to Multiple Opioid Overdoses.

Prehospital Emergency Care, 20(2), 226-229. doi: 10.3109/10903127.2015.1076097

Patrick, S. W., Fry, C. E., Jones, T. F., & Buntin, M. B. (2016).

Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates.

Health Affairs, 35, 1045-1051. doi: 10.1377/hlthaff.2015.1496

Green, T. C., Bowman, S., Davis, C., Los, C., McHugh, K., & Friedmann, P. D. (2015).

Discrepancies in Addressing Overdose Prevention through Prescription Monitoring Programs.

Drug & Alcohol Dependence. doi: 10.1016/j.drugalcdep.2015.05.009

Rutkow, L., Chang, H., Daubresse, M., Webster, D. W., Stuart, E. A., & Alexander, G. (2015).

Effect of Florida’s prescription drug monitoring program and pill mill laws on opioid prescribing and use.

JAMA Internal Medicine, 175(10), 1642-1649. doi: 10.1001/jamainternmed.2015.3931

Rutkow, L., Turner, L., Lucas, E., Hwang, C., & Alexander, G. C. (2015).

Most Primary Care Physicians Are Aware Of Prescription Drug Monitoring Programs, But Many Find The Data Difficult To Access.

Health Affairs, 34(3), 484-492. doi: 10.1377/hlthaff.2014.1085